Witnessing the stock’s movement on the chart, on Thursday, Dexcom Inc (NASDAQ: DXCM) set off with pace as it heaved 0.03% to $68.2, before settling in for the price of $68.18 at the close. Taking a more long-term approach, DXCM posted a 52-week range of $57.52-$93.25.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 39.06%. Meanwhile, its Annual Earning per share during the time was 39.06%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 25.22%. This publicly-traded company’s shares outstanding now amounts to $392.20 million, simultaneously with a float of $386.73 million. The organization now has a market capitalization sitting at $26.74 billion. At the time of writing, stock’s 50-day Moving Average stood at $71.52, while the 200-day Moving Average is $78.37.
Dexcom Inc (DXCM) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Dexcom Inc’s current insider ownership accounts for 1.38%, in contrast to 93.69% institutional ownership. According to the most recent insider trade that took place on Sep 05 ’25, this organization’s Director sold 667 shares at the rate of 80.86, making the entire transaction reach 53,934 in total value, affecting insider ownership by 22,667. Preceding that transaction, on Sep 04 ’25, Company’s EVP, Chief HR Officer sold 1,466 for 80.00, making the whole transaction’s value amount to 117,280. This particular insider is now the holder of 105,223 in total.
Dexcom Inc (DXCM) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.49 per share during the current fiscal year.
Dexcom Inc’s EPS increase for this current 12-month fiscal period is 25.22% and is forecasted to reach 2.57 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 24.04% through the next 5 years, which can be compared against the 39.06% growth it accomplished over the previous five years trading on the market.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
Let’s observe the current performance indicators for Dexcom Inc (DXCM). It’s Quick Ratio in the last reported quarter now stands at 1.35. Alongside those numbers, its PE Ratio stands at $47.75, and its Beta score is 1.42. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.22. Similarly, its price to free cash flow for trailing twelve months is now 46.86.
In the same vein, DXCM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 1.43, a figure that is expected to reach 0.68 in the next quarter, and analysts are predicting that it will be 2.57 at the market close of one year from today.
Technical Analysis of Dexcom Inc (DXCM)
Going through the that latest performance of [Dexcom Inc, DXCM]. Its last 5-days volume of 5.29 million indicated improvement to the volume of 4.23 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 44.27% While, its Average True Range was 46.05.
Raw Stochastic average of Dexcom Inc (DXCM) in the period of the previous 100 days is set at 18.69%, which indicates a major fall in contrast to 56.33% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.96 that was lower than 2.33 volatility it exhibited in the past 100-days period.
